Detection of EGFR T790M Mutation in Pericardial Effusion from a Non-Small Cell Lung Cancer Patient with Erlotinib Therapy

Publisher： Karger

E-ISSN： 1662-6575|6|1|15-20

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.6, Iss.1, 2013-01, pp. : 15-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment of EGFR and KRAS mutation status from FNAs and core‐needle biopsies of non‐small cell lung cancer

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 4, 2015-04 ,pp. : 230-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Treatment with Erlotinib for EGFR Wild-Type Non-Small Cell Lung Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-03 ,pp. : 189-196

Karger

Access to resources Recommend Favorite

Erlotinib Achieved Partial Response in a Non-Small Cell Lung Cancer Patient with Gefitinib-Induced Interstitial Lung Disease

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-09 ,pp. : 464-466

Karger

Access to resources Recommend Favorite

Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene Mutation

By  

Case Reports in Oncology, Vol. 3, Iss. 2, 2010-04 ,pp. : 98-105

Karger

Access to resources Recommend Favorite

Erlotinib in Patients with Previously Irradiated, Recurrent Brain Metastases from Non-Small Cell Lung Cancer: Two Case Reports

By  

Oncology Research and Treatment, Vol. 31, Iss. 3, 2008-02 ,pp. : 123-126

Karger

Access to resources Recommend Favorite